British drugmaker Shire plc said it now plans to invest $460 million in its Lexington campus over the next eight years and hire 750 full-time employees as part of an expansion of its Lexington-based Human Genetic Therapies division that it unveiled last year.
When it outlined its expansion plans in February 2008, the company said it planned to invest $394 million and hire 680 workers.
Shire recently signed a 15-year lease on a new building in Lexington that will house offices and research and development labs for the Human Genetic Therapies division.
The company is leasing the new 160,000-square-foot building at 200 Patriot Way in the Lexington Industrial Park from the owner, Patriot Partners, a joint venture of Mohawk Partners, Atlantic Management, and O'Connor Capital Partners.
Construction is set to begin next year, and Shire plans to occupy the building in 2012.